Received Feb 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | — | — |
Shingrix - sore arm at injection site; Patient felt sick for 24 hours after first dose; This non-serious case was reported by a physician via call center representative and described the occurrence of injection site pain in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced injection site pain (Verbatim: Shingrix - sore arm at injection site) and sickness (Verbatim: Patient felt sick for 24 hours after first dose). The outcome of the injection site pain was unknown and the outcome of the sickness was resolved (duration 24 hrs). It was unknown if the reporter considered the injection site pain and sickness to be related to Shingrix. It was unknown if the company considered the injection site pain and sickness to be related to Shingrix. Additional Information: GSK Receipt Date: 11-FEB-2025 The physician reported that a patient had extremely sore arm at injection site after first dose of Shingrix and felt sick for 24 hours. They want to know if patient should still get the second dose of Shingrix.